CEP-40125
CEP-40125 (RXDX-107) is a modified form of Bendamustine , a DNA cross-linking agent that may cause DNA damage and cell apoptosis. CEP-40125 (RXDX-107) is formed by encapsulating the alkyl ester form of Bendamustine in human serum albumin[1][2].
Product Specifications
CAS Number
1456608-94-8
Product Name Alternative
RXDX-107
UNSPSC
12352005
Target
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cep-40125.html
Smiles
O=C(CCCC1=NC2=CC(N(CCCl)CCCl)=CC=C2N1C)OCCCCCCCCCCCC
Molecular Formula
C28H45Cl2N3O2
Molecular Weight
526.58
References & Citations
[1]Pharmaceutical prodrugs and methods of their preparation and use. WO2018013783.|[2]Croasdell G. The 34th Annual JP Morgan Healthcare Conference. San Francisco, California, USA-January 11-14, 2016[J]. Drugs of the Future, 2016, 41 (1) .
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
